Abstract
Allergy and asthma prevention have always been a priority for patients and patients’ associations. They consider prevention as very important as it is a way to decrease the burden of the disease or even prevent symptoms from occurring. For patients and patients’ associations prevention is also an essential part of disease control.
Preview
Unable to display preview. Download preview PDF.
References
Allergic rhinitis and its impact on asthma, 2001. Journal of Allergy and Clinical Immunology, 108(5), S147–334.
Borres, M.P., Abrahamsson, G., Andersson, B., et al., 2002. Asthma and allergies at school: a Swedish national position paper. Allergy, 57(5), 454–457.
EFA, 1999. European declaration on asthma and allergy prevention. EFA.
EFA, 2001. Asthma and allergy prevention: first priority for patients: in remembrance of Kerstin Hejdenberg, EFA president 1996–2000, 7–9 June 2001, Stockholm, Sweden: abstracts. EFA.
EFA and EAACI, 2000. Patients’ views and values: joint EFA and EAACI round table, Lisbon, Portugal, 4 July 2000: abstracts. EFA.
UCB, 1999. European allergy white paper. Update. UCB Institute of Allergy, Brussels.
WHO, 2003. Prevention of allergy and allergic asthma: based on the WHO/WAO meeting in Geneva 8–9 January 2002. WHO, Geneva.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Valovirta, E. (2006). The patient’s voice in allergy prevention. In: Gilissen, L.J.W.J., Wichers, H.J., Savelkoul, H.F.J., Bogers, R.J. (eds) Allergy Matters. Wageningen UR Frontis Series, vol 10. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3897-6_20
Download citation
DOI: https://doi.org/10.1007/1-4020-3897-6_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3895-2
Online ISBN: 978-1-4020-3897-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)